Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
[15] [37] [38] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
IV delivery allows for achieving optimal serum levels that might be difficult to reach with oral forms
B.TriggleD
Patients on Wegovy may see faster and more dramatic results, particularly because of its higher dosage (up to 2.4 mg)
US$ 26.42
US$ 21.21
US$ 23.46
US$ 20.14
US$ 26.11
US$ 23.01
US$ 28.82
US$ 25.82
US$ 20.79
US$ 29.35
US$ 29.93
US$ 23.19
US$ 29.96
US$ 24.35
